AKC Canine Health Foundation Funds Landmark Clinical Trial on Regenerative Medicine Treatment for Dogs

The AKC Canine Health Foundation (CHF) announces the funding of a landmark clinical trial to establish the evidence-based use of regenerative medicine to treat tendon injury in dogs.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Regenerative medicine is a rapidly developing field with the potential to transform the treatment of canine and possibly human disease.Dr. Shila Nordone

Raleigh, NC (PRWEB) June 26, 2014

The AKC Canine Health Foundation (CHF) is pleased to announce the funding of a landmark clinical trial to establish the evidence-based use of regenerative medicine to treat tendon injury in dogs.

Funded as part of CHF’s Canine Athlete Initiative which seeks to fund research and provide education for dog owners in the rapidly expanding field of canine sports, this newly funded collaborative grant will inform the veterinary community in the use of safe and effective regenerative medicine techniques.

According to Dr. Shila Nordone, CHF Chief Scientific Officer, “Regenerative medicine is a rapidly developing field with the potential to transform the treatment of canine and possibly human disease.” Nordone goes on to say, “Because current regenerative medicine products and techniques vary widely and success stories are anecdotal at best, CHF is committed to funding independent studies that support the evidence-based practice of regenerative medicine.”

Principal Investigators Dr. Jennifer Barrett, MS, PhD, DVM, DACVS, DACVSMR; Dr. Sherman Canapp, DVM, MS, CCRT, DACVS, DACVSMR; and Dr. Victor M. Ibrahim, MD, FAAPMR, will conduct the first blinded, placebo-controlled clinical trial evaluating the effectiveness of platelet-rich plasma and stem cells on the most common sporting injury in dogs: supraspinatus tendonopathy, a shoulder injury that is similar to rotator cuff injury in humans.

In dogs, tendon injuries often progress undiagnosed and result in chronic lameness and pain. If left untreated, scar tissue may form, reducing the function of the joint and surrounding muscle tissue. Through this grant, a collaborative group of veterinary sports medicine specialists across multiple disciplines will determine if regenerative mediScine therapies promote healing through tissue regeneration and reduced scarring.

As dogs are living longer and participating in more sporting events, CHF is committed to being on the leading-edge of novel therapies that will help all dogs stay Fit For Sport, Fit For Life.

CHF is a non-profit organization dedicated to funding research to prevent, treat, and cure canine disease. Visit CHF online at http://www.akcchf.org for more information about the Foundation. Like CHF on Facebook, follow CHF on Twitter @CanineHealthFnd, or connect with CHF on LinkedIn.

# # #

About CHF:

The AKC Canine Health Foundation (CHF) is a non-profit organization dedicated to helping dogs live longer, healthier lives by funding research that helps prevent, treat, and cure canine disease. Established in 1995, CHF’s mission is to advance the health of all dogs and their owners by funding sound, scientific research and supporting the dissemination of canine health information. Through the generous support of the American Kennel Club, Nestlé Purina PetCare, Zoetis (formerly Pfizer Animal Health), dog clubs, and dog owners worldwide, CHF has dedicated more than $40 million to canine health research projects and education programs. Visit CHF online at http://www.akcchf.org for more information.


Contact

Attachments

AKC Canine Health Foundation Logo AKC Canine Health Foundation Logo

AKC Canine Health Foundation Logo